An IV formulation of esomeprazole [Nexium] has been launched in the UK by AstraZeneca

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1431, 2004-01, pp. : 18-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In the year to March 2002, spending on direct-to-consumer (DTC) advertising for a single product in the US was highest for AstraZeneca's esomeprazole [`Nexium'] at $US177 million

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 398, 2003-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

The antipsychotic, quetiapine [AstraZeneca], has been approved in Mexico for use in manic episodes

Inpharma, Vol. 1, Iss. 1394, 2003-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

AstraZeneca has been fined 60 million by the European Commission (EC) for anticompetitive conduct regarding its proton pump inhibitor omeprazole

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 481, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Rosuvastatin [Crestor; AstraZeneca] has received a positive opinion in Japan

Inpharma, Vol. 1, Iss. 1467, 2004-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

An orodispersible formulation of donepezil [Aricept Evess; Eisai] has been launched in the UK for the treatment of Alzheimer's disease

Inpharma, Vol. 1, Iss. 1573, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite